Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hypnosis shows promise for diabetes Self-Care in small trial

NCT ID NCT07279779

Symptom relief Sponsor: Gadjah Mada University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new approach called HypnoDiaCare, which combines hypnosis with diabetes education, to see if it helps adults with type 2 diabetes manage their condition and feel better. Fifty-four participants were split into three groups: one received hypnosis-based education, another received standard diabetes education, and a third watched neutral images. The study measured changes in self-management and quality of life after two sessions. Results could point to a new, non-drug way to support diabetes care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hypnosis-based diabetes self-management education (HypnoDiaCare)
What this could lead to
If it works, this could offer a new, drug-free way to help people with type 2 diabetes better manage their condition and improve their quality of life.
What could go wrong
This is a small, completed trial with only 54 participants, so results may not apply to everyone. The intervention is behavioral, so benefits may vary widely between individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Dec 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 20 years or older * Diagnosed with type 2 diabetes mellitus (T2DM), confirmed via self-report or written recommendation from Puskesmas based on medical records * Able to read and understand Indonesian * Not currently receiving psychological therapy * Willing to attend two intervention sessions * Provided written informed consent Exclusion Criteria: * History of severe psychiatric disorders as self-reported * Currently undergoing psychological treatment or psychotherapy * Severe physical illness or comorbidities that may interfere with participation * Cognitive impairment that may hinder comprehension or procedure adherence * Failure to attend both intervention sessions * Any condition judged by the investigators to interfere with safe participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes mellitus (T2DM)

Contacts and locations

Locations

  • Hypnotic Guided Imagery Laboratory, Faculty of Psychology, Universitas Gadjah Mada

    Yogyakarta, 55281, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.